Management Of Acute Disseminating Encephalomyelitis
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government.
Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT03284801
Recruitment Status : Unknown
Verified September 2017 by Marwa Alsaid Ahmed, Assiut University. Recruitment status was: Not yet recruiting
Acute disseminated encephalomyelitis is an immune-mediated inflammatory demyelinating disease of the central nervous system, which is typically transitory and self-limiting. It is characterized by an acute or subacute encephalopathy with neurological deficits, and magnetic resonance imaging evidence of widespread demyelination that predominantly involves the white matter of the brain and spinal cord. In the absence of specific biological markers, the diagnosis of Acute disseminated encephalomyelitis is still based upon a combination of clinical and neuro imaging features and exclusion of diseases that mimic Acute disseminated encephalomyelitis
Condition or disease
Acute Disseminated Encephalomyelitis
Other: management of acute disseminating encephalomyelitis
clinical audit on management of acute disseminating encephalomyelitis [ Time Frame: within one year ]
To improve diagnosis and management of acute disseminated encephalomyelitis in Neurology Unit of Assiut University Children Hospital and to decrease the mortality and residual deficits from this disease.
The aim of this audit is to measure the current practice within the Neurology Unit of Assiut University Children Hospital team in the diagnosis and management of acute disseminated encephalomyelitis against the recommendations in American Academy of Neurology guidance by using checklist and designed questionnaire.
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Layout table for eligibility information
Ages Eligible for Study:
12 Months to 18 Years (Child, Adult)
Sexes Eligible for Study:
Accepts Healthy Volunteers:
- All patient presented with manifestation of acute disseminating encephalomyelitis admitted in Assiut University Children Hospital
All patient presented with manifestation of acute disseminating encephalomyelitis admitted in Assiut University Children Hospital
Patients presented with viral encephalitis,bacterial meningitis
Cases not fulfilling MRI criteria for diagnosis of acute disseminated encephalomyelitis